Emmanuel Balandya
Muhimbili University of Health and Allied Sciences (MUHAS)
Director, Postgraduate Studies; PI, SPARCo-Tanzania
Tanzania
Prof. Emmanuel Balandya is a physician-scientist with expertise in biomedical sciences, encompassing Physiology, Haematology, and Immunology. He obtained his Medical Degree at the University of Dar-es-salaam, Tanzania (2005); Doctorate Degree at Dartmouth College, USA (2012), and a postdoctoral
fellowship at Harvard Medical School, USA (2014). Following his return to Tanzania, he researched on
immunity and infections in Sickle Cell Disease (through the NIHFIC/ NHLBI/UCSF Global Health Fellowship) and is currently PI of the NIH/NHLBI-funded U01 HL156853 grant titled Sickle Pan - African Research Consortium (SPARCo)-Tanzania, part of the larger SickleInAfrica Consortium involving Tanzania, Nigeria, Ghana, Mali, Uganda, Zimbabwe, Zambia, and South Africa. He is a co-Investigator in several ongoing health research and education capacity-building projects at MUHAS. He is published and has presented his work on national and international platforms. Prof. Balandya is also a Member of the Organizing Committees for the MUHAS Scientific Conference and National NCD Scientific Conference in Tanzania; is a Director of Postgraduate Studies at MUHAS; Board Member of Young Scientists Tanzania (YST), a nationwide Science
Outreach Programme, and consults with the National Institute for Medical Research (NIMR) and Tanzania Commission for Universities (TCU) on matters related to health research and education. He is a scientific reviewer for the Tanzania Journal of Health Research (TJHR), Allergologia et Immunopathologia, Lancet Haematology, Journal of Community Genetics, and PLOS ONE.